
Orforglipron non-inferior to glargine for CV events in T2D
6.10.2026
0:00
10:36
Editor's Pick: Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial (The Lancet, 2026)
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning the cardiovascular-kidney-metabolic continuum, acute triage, surgery and transplant surveillance, and a cluster of major guidance documents that reset everyday pr…
This week's papers:
1. Cardiovascular-Kidney-Metabolic Overlap in Patients Hospitalized for Heart Failure.. JAMA Cardiology 2026.
2. Pharmacological treatment strategies to prevent heart failure across the cardiovascular-kidney-metabolic spectrum: an EJHF Expert Consensus Statement.. European Journal of Heart Failure 2026.
3. Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-dri…. The Lancet 2026.
4. Food and Health: Nutrition for Prevention and Management of Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiolo…. Journal of the American College of Cardiology 2026.
5. PreHEART score for emergency medical services triage of chest pain: a randomised trial.. Heart 2026.
6. No-Touch vs Conventional Vein Grafts in Coronary Surgery: Seven-Year Clinical Outcomes of the SWEDEGRAFT Randomized Clinical Trial.. JAMA Cardiology 2026.
7. Acute cellular rejection after heart transplantation: validation of HEARTBiT, a transcriptomic biomarker.. European Heart Journal 2026.
8. 2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of C…. Journal of the American College of Cardiology 2026.
9. Impact of Undertreated Antithrombotic Therapy on Adverse Patient Outcomes: A Scientific Statement From the American Heart Association.. Circulation 2026.
10. Implementation of cardiac magnetic resonance imaging in everyday cardiology practice.. European Heart Journal 2026.
Listen at https://audioscholar.cc/episode/c8dtfazrcf
Więcej odcinków z kanału "AudioScholar Cardiology Weekly"



Nie przegap odcinka z kanału “AudioScholar Cardiology Weekly”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








